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ABSTRACT 
The differentiation of endometrial stromal cells to decidual cells, a process known as 
decidualization, is essential for the establishment of pregnancy. The decidual tissue produces 
multitude of factors that control a variety of physiological processes at the fetal-maternal 
interface, such as endometrial vasculogenesis, modulation of maternal immune response, spiral 
artery modification and trophoblast invasion. An aberrant decidual response is associated with 
various pregnancy disorders, including spontaneous miscarriage, intrauterine growth restriction 
and preeclampsia. Our study revealed that the expression of Runx1, a transcription factor 
belonging to the runt-domain family, is markedly elevated in the uterine stromal cells during 
decidualization. Conditional deletion of the uterine Runx1 gene led to severe embryo growth 
retardation and pregnancy loss during mid-gestation. Histological analysis of the Runx1-null 
uteri at gestation days 10-12 revealed an abnormally dense decidual tissue resulting from 
enhanced proliferation, impaired differentiation, and lack of apoptosis of stromal cells. The loss 
of Runx1 expression in uterine stromal cells also resulted in a marked impairment in the 
development of maternal blood vessels concomitant with a marked down regulation of several 
angiogenic factors, such as VEGF-A and angiopoietin-2. Furthermore, immunohistochemical 
analysis of smooth muscle actin and cytokeratin in the uterine sections of the mutant mice 
revealed a lack of maternal spiral artery modification and restricted trophoblast invasion. 
Collectively, these studies demonstrated that in the absence of Runx1 the decidua fails to produce 
critical factors that impact blood vessel formation, spiral artery modification, stromal apoptosis, 
and trophoblast migration. Thus, the Runx1-conditional knockout mouse presents an important 
animal model to study the molecular pathways that operate at the maternal-fetal interphase to 
control events that are critical for maintenance of pregnancy.  
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Introduction 
Steroid hormones, estrogen (E) and progesterone (P) critically regulate cell proliferation, 
differentiation, remodeling, and menstrual shedding of the endometrium. In each cycle, under the 
influence of these hormones, the endometrium becomes competent to receive the embryo during 
a short duration of time known as “window of receptivity”. Embryo-uterine interactions leading 
to implantation and establishment of pregnancy occur during this period (1-3). About one third 
of human pregnancies end in spontaneous abortion and among these losses, 22% of them occur 
even before pregnancy is clinically detected. Implantation failure still remains an unsolved 
problem in reproductive medicine and it is the major cause of infertility.  
In murine and human pregnancies, embryos implant by attaching to the luminal epithelium and 
invading into the stroma of the endometrium. In response to E and P, the stromal cells 
surrounding the implanting embryo undergo a remarkable transformation event. This process, 
known as decidualization, is an essential prerequisite for implantation (4-7). It involves 
morphogenetic, biochemical and vascular changes driven by the E and P receptors. The 
development of mutant mouse models lacking these receptors has firmly established the 
necessity of steroid signaling for decidualization. Genomic profiling of mouse and human 
endometrium has uncovered a complex, yet highly conserved network of steroid-regulated genes 
that supports decidualization. In order to advance our understanding of the mechanisms 
regulating implantation and better address the clinical challenges of infertility and endometrial 
diseases such as endometriosis, it is important to integrate the information gained from the 
mouse and human models (8-10). 
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1.2 Literature Review 
Ovarian steroid hormones E and P act in concert to control uterine competency for embryo 
implantation (11-15). In mice, the attachment of the embryo to uterine epithelium occurs on day 
4 of pregnancy. The attachment of the embryo to the uterine epithelium promotes the 
differentiation of the underlying fibroblastic stromal cells into morphologically distinct decidual 
cells, in a process termed as decidualization. Thus, transformed decidual cells have unique 
biosynthetic and secretory properties. They secrete hormones, growth factors and cytokines, 
essential for tissue and vascular remodeling to support the growth and development of the 
embryo. Undoubtedly these timely and orderly changes in the endometrium are critical events for 
maternal-fetal interactions leading to successful term pregnancy (16). In humans, implantation 
occurs 5-9 days after ovulation. While the decidual program in humans is initiated in the absence 
of the embryo, the extent of decidualization increases significantly with the onset of implantation 
and establishment of pregnancy (17). Perturbations in the decidual program may lead to 
pregnancy complications such as ectopic pregnancy, intra-uterine growth restriction, 
preeclampsia and thus, adversely influence fertility (7). 
To understand the molecular basis of pregnancy complications in the human, functional studies 
employing transgenic mouse models are useful (18,19). Indeed studies over the past several 
years have yielded valuable information regarding the mechanisms that regulate implantation. 
This dissertation is focused on the role of transcription factor Runx1 in the regulation of 
decidualization and placentation during early pregnancy.  
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1.2.1 Implantation 
Embryo – uterine interactions leading to implantation involves a series of complex interaction 
between the developing embryo and the uterus (20,21). Major events of the implantation process 
are synchronized development of the embryo to the blastocyst stage and a receptive uterus 
through steroid hormone dependent changes. Lack of this synchronization leads to implantation 
failure. In mice, there is a transitory rise in Estrogen on day 4 of pregnancy known as “nidatory 
estrogen” which is responsible for implantation. Steroid hormones also regulate these processes 
in humans. During the proliferative phase at the first half of the menstrual cycle, estrogen level is 
high. Following ovulation, the second half of the menstrual cycle is dominated by progesterone. 
In response to these hormones, the endometrium undergoes morphological and physiological 
changes. Progesterone transforms the endometrium and creates an uterine milieu ready for 
embryo attachment (2,21-23). Molecular and cellular mechanisms by which these hormones 
coordinate the development of embryo and uterus are poorly understood. 
1.2.2 Decidualization 
Implantation of the embryo into the uterine wall involves a complex and reciprocal relationship 
between the mother and the fetus (20,21). This maternal-fetal dialogue involves an intimate 
interaction between the specialized trophectodermal cells of the embryo and the receptive uterine 
lining of the mother. In mice, the steroid hormones E and P orchestrate the changes in the uterine 
epithelium that make it competent to attach to the blastocyst and initiate the process of 
implantation on day 4 of pregnancy (24,25). 
 In preparation for implantation, the human endometrium undergoes dramatic cyclic cellular and 
molecular developments in response to steroid hormones (2,21-23). A marked rise in the level of 
P along with a moderate increase in the level of E occurs during the post-ovulatory or luteal 
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phase of the cycle. These hormones transform the endometrium and make it receptive for 
embryo attachment (2,21-23). The underlying molecular and cellular mechanisms by which these 
hormones coordinate the development of embryo and uterus are poorly understood. 
1.2.3 Angiogenesis  
Angiogenesis, a characteristic event during implantation and decidualization, is critical for the 
growth and development of embryo. The process involves formation of new blood vessels from 
pre-existing vasculature in the uterus. Several studies have indicated that E and P play an 
important role in this process (26-28). Vascular endothelial growth factor (VEGF) (29,30) is 
recognized as a key regulatory growth factor for angiogenesis (31). Targeted deletion of the gene 
encoding Vegf results in embryonic death due to abnormal blood vessel formation (32,33). 
Certain members of the angiopoietin family including angiopoietin 1 and 2 are expressed in the 
endometrium and are known to modulate angiogenesis by promoting vascular maturation and 
remodeling (34,35). While it has been reported that E and P regulate the expression of these 
genes in the endometrium (36,37), the exact mechanism and signaling pathways by which these 
hormones regulate angiogenesis remain unclear. 
1.2.4 Placentation 
The placenta, a transient organ, physically connects the mammalian embryo to its mother. 
Establishment of this connection is absolutely critical for the growth of the embryo. The 
specialized cells of embryo including the trophoblast, endoderm, and extraembryonic mesoderm 
form early in development and attach the embryo to the uterus. During early placentation, the 
trophectoderm proliferates to form the ectoplacental cone, which later becomes the 
spongiotrphoblast layer. The outermost trophoblast cells of the ectoplacental cone differentiate 
and form the trophoblast giant cells, which form the interface with the maternal decidua. 
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Endoderm cells from the inner cell mass (ICM) form the Reichert’s membrane. After 
gastrulation on day 7.5, the extraembryonic mesoderm forms the visceral yolk sac which 
differentiates to form hemangioblasts (7). 
These cell lineages establish the three layers of the murine placenta. The zone closest to the 
chorionic plate is the labyrinth zone (38). Surrounding the labyrinth is the junctional zone of the 
murine placenta, which is composed of fetal spongiotrophoblasts and trophoblast glycogen cells. 
This is followed by a layer of trophoblast giant cells. The three layers of the murine placenta 
provide the means for communication between the mother and fetus. Although gene expression 
studies are being carried out to understand the functions of trophoblast lineages, the mechanism 
underlying the placental formation is not clear (5,39,40). 
Embryonic day 10 is a critical juncture in the rodent placenta, when the chorioallantoic 
circulation becomes the primary support for the embryo. The placenta forms an essential 
maternal-fetal interface to exchange oxygen and nutrition to the growing fetus. During 
placentation, the fetal trophoblast cells invade into maternal decidua to reach spiral arteries and 
transform them into dilated vessels (41-46). As a result of trophoblast invasion, spiral arteries 
undergo dilation up to several times their original lumen diameter (47). Defects in invasion of 
fetal trophoblast cells into maternal decidua can result in various clinical problems such as, 
spontaneous abortion, preeclamsia, and intra uterine growth restriction (IUGR) (29,30,38,48-50). 
Due to the advancement of gene targeting technology, mouse models are becoming useful to 
study human pregnancy disorders (51,52) 
1.2.5 Runx1- a member of Runx family of transcription factors 
The Runx transcription factors derive their names from the founding members of the family, the 
drosophila runt genes. These genes play an important role in morphogenesis, sex determination 
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and eye formation in the fly (53). There are three family members including, Runx1, Runx2 and 
Runx3. RUNX genes encode the α-subunit, also termed as polyomavirus enhancer-binding 
protein 2 (PEBP2) α/core-binding factor (CBF) α, and combine with the β subunit 
(PEBP2β/CBFβ) to form the heterodimeric transcription factor (54,55). All three Runx proteins 
harbor a conserved 128 amino acid runt domain, which mediate hetero-dimerization with CBFβ 
and binding to DNA (56,57). The three RUNX genes are critical for the development of specific 
tissues. While Runx1 plays an important role in physiology of blood cells, Runx2 is critical for 
bone and Runx3 is critical for neurons of the dorsal root ganglia (58). 
The Runx1 gene was first cloned in 1991 and targeted inactivation of this gene in mice led to 
complete blockade of definitive hematopoiesis and embryonic lethality between E12.5 and E13.5 
(59,60). It has been reported that Runx1 is expressed in hematopoietic cells in the yolk sac and 
endothelial cells within the vitelline and umblical arteries of embryo at E10.5 (61). Runx1 also 
plays a supportive role in bone formation and can mediate oncogenic transformation to acute 
mylogenous leukemia (62-65). 
1.2.6 Runx genes and reproductive tissues 
Runx-dependent function in reproductive physiology has not been established so far. Runx1 and 
Runx2 are expressed during development in Müllerian ducts, which ultimately form the uterus, 
cervix, and the upper part of the vagina (66). In contrast, the expression of Runx1 and Runx2 is 
absent in Wolffian ducts, which form the epididymis and vas deferens. The functional role of 
Runx genes in the development and function of female reproductive tract remains unknown. In 
the adult, the ovarian expression of all three Runx genes have been reported previously (67-69). 
Runx1 and Runx2 have been shown to regulate key events during corpus luteum formation in 
mice and rat (70-72). 
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In pathophysiology, Runx1 expression has been associated with the development of endometrial 
invasive carcinoma. Interestingly, previous studies also indicated that ectopic expression of 
Runx1 leads to metastasis in a murine orthotopic model (73,74). While it has been reported 
previously that Runx1 expression is upregulated in endometriosis, no information is available 
about its uterine expression and its role during pregnancy and pregnancy related disorders.  
My thesis is focused on the investigation of functional role of Runx1 at the maternal–fetal 
interface during early pregnancy. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Animals and Tissue Collection 
Mice were maintained in the designated animal care facility at the College of Veterinary 
Medicine of the University of Illinois, Urbana-Champaign, according to the institutional 
guidelines for the care and use of laboratory animals. Control animals have two alleles flanked 
by lox P sites, termed Runx1 “floxed” animals designated as Runx1fl/fl.  Experimental animals 
have two alleles flanked by lox P sites as well as one allele expressing cre-recombinase under the 
progesterone receptor promoter, termed Runx1 “deleted” animals designated as Runx1d/d.  
To generate the conditional Runx1-null mice (Runx1
d/d
), Runx1-floxed (Runx1
fl/fl
) (75) mice were 
mated with PR-Cre knock-in mice (76). For breeding studies, cycling female Runx1
fl/fl
 mice and 
Runx1
d/d
 were housed with wild-type C57BL/6 male mice (Charles Rivers) for 6 months. The 
presence of a vaginal plug after mating was designated as day 1 of pregnancy. The number of 
litters and pups born were recorded at birth to assess the fertility status. 
Mice were sacrificed by CO2 overdose, and uterine, ovarian and other tissues were collected at 
various days of gestation. Tissues were either placed in fixative (10% Neutral Buffered 
Formalin-NBF, Fisher) or flash frozen in liquid nitrogen or subsequently stored at -80 
o
C.  
Superovulation experiments were carried out using 7-8 week old female mice. The mice  were 
injected intraperitoneally with 5 IU of Pregnant Mare Serum Gonadotropin (PMSG) and 48 
hours later by 5 IU of human Chorionic Gonadotropin (hCG) and killed 16-18 h post hCG 
administration. Oocytes were flushed from the oviducts and counted. PMSG and hCG were 
purchased from Sigma Aldrich (St. Louis, MO). 
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Delayed Implantation was carried out by ovariectomizing mice on day 4 (morning) of pregnancy 
and injected subcutaneously with P in oil vehicle (2 mg) daily from days 5-7. To terminate 
delayed implantation and induce blastocyst attachment, the P-primed delayed implanting mice 
were given an injection of E in oil (50 ng) on the fourth day of the delay (day 8). Mice were 
euthanized at different time points after E injection and uteri were collected. Both progesterone 
and estrogen were purchased from Sigma Aldrich (St. Louis, MO). 
Artificial decidualization reaction (77) was carried out as described previously (78). Mice of 7-8 
weeks of age were ovariectomized and rested for two weeks. Mice were primed with three daily 
subcutaneous injections of 100 ng of 17α - estradiol in 0.1 ml cottonseed oil. Mice were given a 
brief rest without injections for two days and then received three daily injections of 2 mg P plus 
6.7 ng of 17β - estradiol in 0.1 ml cottonseed oil. Six hours after the third injection, animals were 
anaesthetized and one horn of the uterus was stimulated by injecting 20 ul of cottonseed oil into 
the uterine horn. Daily injections of progesterone and estrogen were continued until the 
collection point for the uteri. The uteri were then extracted, weighted, and processed for 
immunohistochemical analysis. 
Serum samples were collected on days 8, 10 and 12 of pregnancy after animals were euthenized 
by CO2 overdose. Serum progesterone and estrogen concentrations were measured by 
radioimmunoassay (RIA) at the Ligand Core Facility of University of Virginia at Charlottesville. 
The values are expressed as mean +/- SEM. 
2.2 Histology 
Uterine and ovarian tissues collected on various days of gestation were fixed in neutral buffered 
formalin, processed and embedded in paraffin blocks. Sections (4μm) were utilized for 
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Hematoxylin and Eosin staining (H&E) and histological analysis. Image J software was used for 
morphometric measurement of decidual thickness. 
2.3 Immunohistochemistry/Immunofluorescence  
Uterine tissues were processed and subjected to immunohistochemistry as described previously (79). 
Paraffin-embedded tissues were sectioned at 4 μm and mounted on microscopic slides. Sections were 
deparaffinized in xylene, rehydrated through a series of ethanol washes, and finally rinsed in water. 
Antigen retrieval was performed by immersing the slides in 0.1M citrate buffer solution at pH 6.0, 
and by heating in the microwave for 25 min. The slides were allowed to cool and endogenous 
peroxidase activity was blocked by incubating sections in 0.3% hydrogen peroxide in methanol for 
15 min at room temperature. After washing with PBS for 15 min, the slides were incubated in a 
blocking solution for 1 h before incubating them in primary antibody overnight at 4°C with 
antibodies specific for RUNX1(SC-28679), Progesterone Receptor (PGR-A0098, DAKO), CD31(BD 
Pharmingen 557355), Ki67(BD 550609), Prolactin Related Protein (PRP, -AB1293, Chemicon), 
Prolactin Like Protein –B (PLP-B, AB 1291, Chemicon), angiopoietin2 (ANG2, SC-7017), vascular 
endothelial growth factor –A (VEGF-A, SC-152), Cytokeratin8 (hybridoma bank, Troma 1), α-
smooth muscle actin (α-SMA, ab-5694), platelet endothelial cell adhesion molecule (PECAM, SC-
56), forkhead box protein O1 (FOXO1, Epitomics 1874-1) and Connexin 43 (Invitrogen 35-5000). 
Immunoflouerscence was carried out using Alexa fluor 488 or cy3 conjugated secondary antibodies 
from Jackson immunology and counter stained with DAPI. Immunofluorescence for all the proteins 
stained was repeated in uterine sections collected from 5 -8 animals. 
2.4 Western blot analysis 
Whole cell extracts were prepared from mouse uterine decidual cells isolated from day 8 
pregnant uteri as described previously (80). Western blot analysis was performed following the 
protocol described previously (81). Briefly, cells were washed with ice-cold balanced solution 
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and lysed with the radioimmuneprecipitation assay buffer (0.1% SDS, 0.5% sodium 
deoxycholate, 1% Nonidet P-40 in PBS) containing protease inhibitor mixture, 
phenylmethylsulfonyl fluoride (PMSF, 0.1 mg/ml), and phosphatase inhibitor (1:1000; Sigma-
Aldrich). The cells were passed through a 25-gauge syringe and centrifuged at 12,000 rpm for 10 
min to remove the cell debris.  of The protein (20–50 μg) extract was analyzed by SDS-PAGE 
and transferred to polyvinylidene fluoride membrane (Amersham Biosciences). The membrane 
was then blocked with 5% BSA in Tris-buffered saline with 0.1% tween 20 for 1 h at room 
temperature, followed by incubation with a primary antibody against Runx1, or calnexin. The 
blot was then incubated with the corresponding HRP-conjugate secondary antibody for 1hr at 
room temperature. Chemilumescence was utilized to detect HRP. 
2.5 Alkaline Phosphatase Activity 
Frozen tissue sections were used to detect alkaline phosphatase activity. Frozen tissue sections 
were thawed at room temperature for 10 minutes and fixed onto slides by incubating in Neutral 
Buffered Formalin (NBF) for 5 minutes. Following fixation, slides were washed in water and 
incubated in dark at 37
 o
C for 30 minutes in 2mM a-naphthyl phosphate (Sigma Aldrich) and 
4mM Fast Violet (Sigma Aldrich) in 0.1 M Tris HCL, pH 8.7. Sections were again washed in 
water to remove excess reagents and  then cover slipped. 
2.6 Quantitative real time PCR analysis (QPCR)   
Uterine tissue was homogenized and total RNA was extracted by using TRIZOL reagent, 
according to the manufacturer’s protocol. cDNA was prepared by standard protocols. cDNA was 
amplified by quantitative PCR using gene-specific primers and SYBR Green probes (Applied 
Biosystems, Warringtom, UK). The expression level of Rplpo (36B4), a ribosomal 
phosphoprotein was used as internal control. For each treatment, the mean Ct and standard 
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deviation were calculated from individual Ct values obtained from three replicates of a sample. 
The normalized Ct in each sample was calculated as mean Ct of target gene subtracted by the 
mean Ct of internal control gene. After normalization, ΔΔCt was then calculated as the 
difference between the Ct values of the control and treatment sample. The fold change of gene 
expression in each sample relative to a control was computed as 2
–ΔΔCt 
(82). The mean fold 
induction and standard errors were calculated from three or more independent experiments. 
2.7 TUNEL & Dolichos Biflorus Agglutinin (DBA) staining 
TUNEL staining was carried out following manufacture’s protocol (TUNEL based apoptosis 
detection assay, R&D systems, catalog # 4812-30-K). Uterine sections were deparaffinized by 
washing in xylene twice for 5 minutes each. Following this, slides were rehydrated and incubated 
with 1ug/ml proteinase K for 15 min at room temperature. After washing in PBS, sections were 
incubated with TUNEL reaction mixture for 60 min in a humid chamber at 37 
o
C. The slides 
were washed and incubated with FITC-conjugate for 30min at 37 
o
C. The slides were 
counterstained with DAPI following washings in PBS and cover slipped. 
Day 10 – day 12 paraffin sections were deparaffinized using xylene and rehydrated by washing 
them through a series of alcohol solutions and a final wash in water. Slides were then incubated 
in 1% BSA for 30 minutes at room temperature. Sections were then incubated with DBA 
solution in BSA (vector labs, catalogue # B-1035) at 37 ºC for 2hrs. After washing, the slides 
were incubated with AEC for 25 min at room temperatures. Slides were cover slipped after 
washing the slides twice in PBS. 
2.8 Statistical Analysis  
Statistical analysis was performed by t-test or ANOVA. The values were expressed as mean ± 
SEM and considered significant if p < 0.05. 
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2.9 Quantitation using ImageJ 
Java based image analysis software ImageJ (http://rsb.info.nih.gov/nih-image/), was utilized for 
the quantification of immunofluorescence of different proteins as described earlier (83,84).  
Thickness of decidual sections which were previously stained with hematoxylin and eosin were 
also measured using this software. Stained uterine sections from different samples (n=8) were 
used for quantitation. 
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CHAPTER 3 
RESULTS 
3.1 Estrogen induces Runx1 expression in mouse uterus during early pregnancy 
To understand the molecular basis of steroid hormonal regulation of implantation, it is critical to 
identify the steroid-regulated gene networks that underlie this process. In this study, we used a 
well-established delayed-implantation mouse model in which embryo attachment to the uterus 
depends on the administration of estrogen to progesterone-primed ovariectomized pregnant uteri. 
Using mouse oligonucleotide microarrays, we compared mRNA profiles of uteri of pregnant 
mice treated with progesterone alone or progesterone plus an implantation-initiating dose of 
estrogen (15,85). Our studies identified several mRNAs that were up- or down-regulated in the 
uteri of mice undergoing delayed implantation after 24 h of estrogen administration. One of the 
mRNAs whose level was robustly enhanced after estrogen treatment encoded the transcription 
factor, Runx1. The Runx1 protein expression during delayed implantation was investigated by 
immunohistochemistry (Fig. 1). The expression of Runx1 was not detectable in the stromal cells 
of uterine sections of progesterone-treated delayed animals before estrogen administration (Fig. 
1, panel A). The level of Runx1 protein increased dramatically in the stromal cells underlying the 
implanted embryo in response to estrogen treatment (Fig. 1, panel B).  
We further confirmed the estrogen regulation of Runx1 in non-pregnant ovariectomized mice 
treated with estrogen by immunohistochemistry. As shown in Fig. 2, a marked induction in 
Runx1 expression was observed in uterine stromal cells in response to estrogen treatment (panel 
B), whereas weak Runx1 expression was seen in oil-treated control uteri (panel A). 
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3.2 Spatio-temporal expression of Runx1 during early pregnancy 
We next examined the spatio-temporal expression of Runx1 in pregnant mouse uteri using 
QPCR and immunohistochemistry. While Runx1 mRNA levels were low on day 4, a marked 
increase in Runx1 expression was observed on day 5 of pregnancy. A significant level of Runx1 
expression continued untill day 10 of gestation (Fig. 4a). Consistent with the RNA profile (Fig. 
3), we detected nuclear expression of Runx1 in stromal cells at the implantation site on day 5 of 
pregnancy (Fig. 4b). As pregnancy progressed to day 8, the expression of Runx1 continued in the 
decidualizing stromal cells (Fig. 4c-e). The expression of Runx1 then declined on day 10 of 
gestation (Fig. 4f). These results showed that Runx1 is localized in differentiating stromal cells 
and suggest a possible role of this transcription factor during decidualization process. 
3.3 Uterine ablation of Runx1 leads to severe sub fertility  
Global deletion of Runx1 gene is embryonic lethal, necessitating the development of conditional 
deletion of this gene to study its functions during implantation (60,86). We employed the Cre-
LoxP strategy to create conditional knockout of Runx1 in the uteri of adult mice. Transgenic 
mice expressing Cre under the control of the progesterone receptor (PR) promoter were 
previously used to ablate “floxed” genes selectively in cells expressing PR, including uterine 
cells (80,87-89). We, therefore, crossed the PR-Cre mice with mice harboring the “floxed” 
Runx1 gene to create Runx1
d/d
 mice. We confirmed the deletion of Runx1 in the uteri of these 
mutant mice by QPCR, immunohistochemistry, and western blot analysis. As shown in Fig. 5, 
neither Runx1 mRNA (panel A) nor Runx1 protein (panels B and C) was detected in uteri of 
Runx1
d/d
 mice on day 8 of pregnancy, confirming successful abrogation of the Runx1 gene in 
uteri of Runx1
d/d
 mice. 
We next assessed the impact of Runx1 ablation in female fertility by carrying out a six-month 
breeding study. As shown in Table 1, an average of 1.9 pups per litter were born to Runx1
d/d 
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mice, while an average of 7.0 pups per litter were born to Runx1
fl/fl
 mice. These results indicated 
a severe fertility defect in Runx1-null females (Table 1). 
3.4 Ovarian function is unaffected in Runx1d/d female mice 
To investigate the cause of subfertility in Runx1
d/d 
females, we examined their ovarian function 
by inducing superovulation. Prepubertal Runx1
fl/fl
 and Runx1
d/d 
mice were treated with a regimen 
of gonadotropin hormones as described in Materials and Methods. We observed that, upon 
gonadotropin stimulation, the number of eggs produced by Runx1
d/d 
was comparable to that 
produced by the Runx1
fl/fl 
females (Table 2). Ovarian sections collected from Runx1
fl/fl 
and 
Runx1
d/d 
pregnant females on day 8 of pregnancy showed formation of corpora lutea (Fig. 6A, 
panels a & b). In further support of normal ovarian activity, the serum levels of progesterone and 
estrogen were comparable in Runx1
fl/fl 
and Runx1
d/d 
females on day 8 of pregnancy (Fig. 6B). 
Collectively, these results suggested that the subfertility of Runx1
d/d 
females is not due to 
impairment
 
in the hypothalamic-pituitary-ovarian axis or lack of fertilization, but is likely due to 
defective implantation or pregnancy failure following implantation. 
3.5 Subfertility in Runx1d/d mice is due to a defect in uterine function 
To further investigate the fertility defect, blastocysts were flushed from Runx1
fl/fl
 and Runx1
d/d 
uteri and counted. No differences in the number or in morphology was observed in the two 
genotypes (data not shown). Examination of pregnant uteri from Runx1
fl/fl
 and Runx1
d/d
 mice on 
days 6-7 of gestation showed normal implantation sites (Fig. 7A). Expressions of alkaline 
phosphatase (Fig. 7B), Bone morphogenetic protein 2 (Bmp2) and Core enhancer binding protein 
beta (Cebp/β ) (Fig. 7C), markers of stromal differentiation (80,90), were also comparable in the 
uteri of Runx1
fl/fl
 and Runx1
d/d 
mice, demonstrating that the early phases of decidualization were 
not affected in Runx1
d/d 
mice. However, we observed that a significant number of embryos failed 
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to grow after day 10 of gestation and began to show signs of resorption (Fig. 8A). Upon 
dissection and removal of outer serosa and myometrial layers, it was apparent that the Runx1
d/d 
endometrial component exhibited distinct hemorrhage (Fig. 8c&d). We further dissected the 
implantation sites and observed that unlike Runx1
fl/fl 
samples, which had distinct embryos, 
trophoblast layers and decidua (Fig. 8A-e), Runx1
d/d 
samples showed signs of embryo resorption 
with a dense decidua (Fig. 8A-f). As pregnancy progressed to day 12, many resorbed embryos 
were noted in Runx1
d/d
 uteri (Fig. 8B-h). Dissection of implantation sites from Runx1
fl/fl
 uteri 
revealed normal and healthy embryos (Fig. 8B-i), whereas most of the embryos in Runx1
d/d
 uteri 
were resorbed (Fig. 8B-j).  
3.6 Histological analysis of mid pregnancy implantation sites 
Histological analysis showed that decidua from day 10 and day 12 Runx1
fl/fl
 mice were well 
vascularized (Fig. 9, A- a&c). With the progression of gestation, the decidua becomes thinner to 
accommodate the growing embryo, which was clearly evident in Runx1
fl/fl
 mice (as shown by the 
arrow in Fig. 9A- a&c). In contrast, the deciduas from Runx1
d/d
 uteri were dense and 
avascularized (Fig. 9A- b&d). No obvious decidual regression was observed in these mice with 
the progression of pregnancy. To further support this observation, we measured the decidual 
thickness by utilizing ImageJ software. Uterine sections from Runx1
fl/fl 
and Runx1
d/d 
mice on day 
10 and day 12 of pregnancy were used for these analyses. Our study revealed that deciduas from 
Runx1
d/d 
mice were twice as thick as the deciduas from control mice (Fig. 9B). Taken together, 
these results indicated that in the absence of uterine Runx1, the decidua fails to undergo 
regression during  the progression of pregnancy. 
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3.7 Deletion of Runx1 leads to persistent stromal cell proliferation in the uterus  
To gain an insight into the underlying mechanism of non-regressed decidua in Runx1
d/d 
mice, we 
monitored uterine proliferation. To specifically address the proliferation of uterine stromal cells, 
we performed co-localization of KI67, a marker of cell proliferation, and PR (91) in uterine 
sections on day 10 of pregnancy. As shown in Fig. 10a, an abnormally high numbers of PR 
positive decidual cells were observed in Runx1
d/d 
uteri compared to Runx1
fl/fl
 controls. Upon co-
localization with KI67, we found that in contrast to Runx1
fl/fl 
decidual cells, decidual cells in 
Runx1
d/d 
uteri were highly proliferative (Fig. 10, compare c and d). Consistent with this 
observation, we noted a marked enhancement in the expression of cyclin D3 in Runx1
d/d
 uterine 
sections compared to uterine sections from Runx1-intact mice (Fig. 11A). We also observed that 
the mRNA levels of Cdkn1b and c, inhibitors of cell cycle, were significantly lower in Runx1
d/d
 
uteri compared to Runx1
fl/fl 
controls (Fig. 11B). Collectively, these results indicate that Runx1 
regulates cyclins and cyclin-dependent kinase inhibitors in uterine stromal cells and causes 
enhanced proliferation.  
A recent report has shown that downregulation of a transcription factor, Foxo1, in human 
endometrial stromal cells promotes cellular proliferation by regulating Cdkn1c and cyclins (92). 
Impaired Foxo1 expression has been associated with proliferative endometrial disorders such as 
endometriosis and endometrial cancer (93,94). When we monitored the expression of Foxo1, we 
noted with interest a marked down regulation of Foxo1 in uterine sections of Runx1
d/d
 compared 
to Runx1
fl/fl 
uteri (Fig. 12 compare c & d). Conversely, TUNEL staining showed a decrease in the 
number of apoptotic decidual cells in Runx1
d/d 
uterine sections compared to Runx1
fl/fl 
controls 
(Fig. 13 compare c & d). The apparent lack of apoptotic cells in the abnormally dense decidua of 
Runx1
d/d
 mice further confirms that uterine ablation of Runx1 leads to extensive proliferation and 
a decline in apoptosis.  
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3.8 Impaired terminal differentiation of decidual cells in Runx1d/d uteri 
Decidualization of stromal cells involves proliferation followed by differentiation. Since uteri 
from Runx1
d/d
 mice show extensive proliferation, it was of interest to determine whether the 
decidual cells are able to undergo terminal differentiation. We, therefore, monitored the 
expression of well-known biomarkers of terminal differentiation such as Prl8a2 (dPRP) and 
Prl6a1 (PLP-B) (result not shown) (95-99). As shown in Fig. 14, the expression of Prl8a2 
(dPRP) was markedly downregulated in the decidual cell of Runx1
d/d
 uteri compared to Runx1-
intact control uteri.  
The gap junction protein Connexin 43 or Gja1 has been reported previously to be expressed in 
differentiating stromal cells during decidualization (88). We next investigated whether the 
expression of Gja1 was altered in Runx1
d/d
 decidua on day 9 of pregnancy by QPCR and 
immunohistochemistry. Our studies revealed that the expression of connexin 43 mRNA and 
protein was markedly down regulated in Runx1
d/d
 uteri compared to Runx1
fl/fl
 control (Fig. 15A 
& B). Collectively, these results indicate that uterine ablation of Runx1 impairs terminal 
differentiation of stromal cells. 
3.9 Runx1
d/d
 mice exhibit impaired angiogenesis during early pregnancy 
Our previous studies indicated that a loss of gap junction communication mediated by connexin 
43 between decidual cells impairs neovascularization during early pregnancy (88). Since the 
expression of connexin 43 is downregulated in Runx1
d/d 
uteri, we next investigated the levels of 
angiogenic factors such as angiopoietin 2 and Vegf-A in Runx1
fl/fl 
and Runx1
d/d 
uteri on day 9 of 
gestation (Fig. 16). Our studies revealed a marked downregulation of angiopoietin 2 and Vegf-A 
mRNAs (Fig. 16 A and B) as well as angiopoietin 2 and Vegf-A proteins (Fig. 16C) in Runx1-
null uteri. 
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Consistent with this observation, our studies revealed impaired angiogenesis as indicated by the 
expression of PECAM, a well-known endothelial biomarker (77,100,101), in Runx1
d/d 
uteri (Fig. 
17). While vascular network was well organized in Runx1
fl/fl 
uteri, we noted disorganized 
vascular network with reduced PECAM staining in Runx1
d/d
 (Fig. 17, compare a and b). 
Collectively, these results indicated that attenuation of stromal differentiation mediated by the 
loss of Runx1 impairs angiogenesis during early pregnancy. 
3.10 Abnormal maternal vascular remodeling and impaired trophoblast invasion in       
Runx1
d/d 
decidua during mid-pregnancy 
Maternal spiral artery modification manifested by the loss of α-smooth muscle actin (α-SMA) in 
spiral artery, is a characteristic feature during mid-pregnancy (45,102,103). This modification is 
achieved when the invading trophoblast cells reach the spiral artery. Since Runx1
d/d
 uteri exhibit 
dense decidua, it raises an interesting possibility that trophoblast cells are unable to migrate 
through dense decidua to reach and transform the maternal spiral arteries. To investigate this 
possibility, we monitored the expression of α-SMA in uterine spiral arteries of Runx1fl/fl and 
Runx1
d/d
 mice on day 12 of pregnancy (Fig. 18). SMA staining on spiral arteries at four specific 
regions in the maternal decidua was closely investigated. Staining in radial artery (Fig. 18A-a 
and 18B-e), spiral artery in myometrium (Fig. 18A-b and 18B-f), distal region of the 
endometrium (at the edge of decidua close to myometrium) (Fig. 18A-c and 18B-g) and 
proximal region (closer to labyrinth) (Fig. 18A-d and 18B-h) were observed. In Runx1
fl/fl 
uteri, as 
expected, the radial artery showed intense α-SMA staining (Fig. 18A-a). The staining was less 
intense in the myometrial spiral artery (Fig. 18A-b), very weak in the distal artery (fig 18A-c) 
and was completely absent in the proximal artery (Fig. 18A-d). On the other hand, Runx1
d/d
 uteri 
exhibited distinct α-SMA staining in the spiral arteries at all four regions (Fig. 18B-e, f, g and h). 
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Persistent expression of α-SMA in Runx1d/d distal and proximal endometrial spiral arteries 
clearly suggests that vascular remodeling is affected by the loss of Runx1.  
We next investigated the invasion of trophoblasts in Runx1
fl/fl 
and Runx1
d/d 
decidua by 
monitoring the expression of cytokeratin 8 (Troma 1), a marker of trophoblast cells (Fig. 19). 
Cytokeratin 8 positive migrating trophoblasts were clearly observed, in maternal decidua of 
Runx1
fl/fl 
uteri. However, deciduas of Runx1
d/d 
uteri were totally devoid of cytokeratin 8 positive 
invading trophoblastic cells. Since endovascular invasion of trophoblast cells into spiral arteries 
leads to modification and the loss of the smooth muscle layer (104), we next co-localized 
cytokeratin 8 and α-SMA in uterine sections of Runx1fl/fl and Runx1d/d uteri on day 12 of 
pregnancy (Fig. 20). Our results showed that in the Runx1
fl/fl 
uterine sections, as expected, spiral 
arteries proximal to the placenta were positive for cytokeratin 8 with weak α-SMA staining (Fig. 
20b). In contrast, the proximal spiral arteries in Runx1
d/d uterine sections exhibited strong α-SMA 
staining and minimal cytokeratin 8 staining (Fig. 20d). To rule out the possibility that there 
might be a delay in trophoblast migration, double immunofluorescence was  carried out also in 
pregnant uteri on day 15 of pregnancy (Fig. 21). Our studies revealed extensive endovascular and 
interstitial trophoblast migration all the way up to the myometrium in Runx1
fl/fl
 decidua (Fig. 
21a). However, pregnant Runx1
d/d 
uteri exhibited impaired trophoblast migration (Fig. 21c) and 
spiral artery modification (Fig. 21d) even in day 15. These results indicate that trophoblast 
migration is inhibited in Runx1
d/d
 mice up to day 15 of pregnancy, which in turn contributes to 
insufficient spiral arterial modification. This led to restricted growth of fetus in Runx1 
d/d 
uteri. 
Interestingly, these are characteristic features of shallow placentation (30). 
Previous studies have suggested that uterine natural killer cells or uNK (78), which are 
abundantly present in the decidua, mediate initial stages of remodeling in the spiral artery 
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(102,105-108). We, therefore, investigated whether poor spiral artery remodeling is due to any 
change in uNK cell population in Runx1
d/d 
decidua by monitoring the expression of Dolichos 
biflorus agglutinin (DBA) lectin, which marks the uNK cells (Fig. 22). We observed that DBA 
positive uNK cells in Runx1
d/d 
decidua (Fig. 22c) were at least 25-30% more in comparison to 
control Runx1
fl/fl
 decidua (Fig. 22a). This was due to the persistent proliferation of uNK cells in 
Runx1
d/d 
decidua as indicated by co-localization of DBA and Ki67 (Fig. 22, compare b & d). 
Taken together, these results indicated that deletion of Runx1 in stromal cells perturbed the 
differentiation program and altered the decidual environment. This in turn affected maternal-fetal 
interactions causing insufficient blood and nutrient flow to the growing fetus, leading to fetal 
growth restrictions and fetal death.  
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CHAPTER 4 
DISCUSSION 
 
Successful implantation in rodents is dependent on the nidatory surge of estrogen on day 4 of 
pregnancy (2,3). While the implantation-inducing action of estrogen has been known for a long 
time, the factors that are functioning downstream of estrogen signaling to regulate implantation 
remain largely unknown. Gene expression profiling was useful in identifying Runx1 as one of the 
mediators of estrogen action in uterus during delayed implantation. Runx1 belongs to Runt 
family of transcription factors, which are known to play critical role during development. In this 
study we report for the first time the expression of Runx1 in uterine stromal cells during early 
pregnancy. We further show that the expression of Runx1 coincides with the decidual phase of 
pregnancy. While it is clear that estrogen induces Runx1 expression in the uterus, the exact 
mechanism by which this hormone promotes Runx1 expression remains unknown.  
Analysis of Runx1-deficient uteri indicated persistent proliferation of endometrial stromal cells 
during decidualization. While this did not affect the early stromal differentiation program as 
indicated by the expression of alkaline phosphatase, Bmp2 and C/ebpβ, we observed a marked 
defect in terminal differentiation of endometrial stromal cells due to ablation of Runx1. This was 
confirmed by the altered expression of a panel of biomarkers of stromal differentiation including 
Gja1, Prl8a2 and Prl6a1 in Runx1-null uteri. It is known that terminal differentiation of 
endometrial stromal cells is critical for establishment of pregnancy by entering the apoptotic 
pathway. This regression of decidua is pivotal for accommodation of growing fetus. Impaired 
terminal differentiation of stromal cells and lack of apoptosis in Runx1 deficient uteri led to 
dense decidua, which failed to undergo regression and support maintenance of pregnancy. 
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Silencing Foxo1 in differentiating human endometrial stromal cells promotes proliferation (92) 
which is similar to the observation in Runx1 mice. Interestingly a conditional mutant of Foxo1 
exhibits similar phenotype as Runx1 ablated mice (Dr. DeMayo’s lab, unpublished observation). 
This raises the interesting possibility that Foxo1 might be a downstream target of Runx1 in the 
uterus during early pregnancy. Further detailed studies are needed to conclusively prove this 
hypothesis.  
Tissue remodeling plays a critical role during decidualization and placentation, which involves 
changes in extra cellular matrix (ECM). This process is mediated by a variety of factors 
including transcription factors, proteases, cell surface receptors, and growth factors (102). Any 
modification in ECM turnover or degradation could affect decidual regression and 
reorganization. It is possible that impairment in terminal differentiation program in Runx1
d/d
 
decidua may also affect the expression of ECM molecules such as MMPs and TIMPs, causing a 
failure in decidual regression and dysregulated tissue remodeling (109,110). We speculate that 
the loss of Runx1 from stromal cells adversely affects the communication between stromal cells 
and release of factors essential to degrade extra cellular scaffolding affecting tissue and vascular 
remodeling. In totality, these defects result in shallow implantation, poor fetal-maternal 
circulation, inadequate embryonic development, and ultimately fetal death. 
It has been shown previously, that stromal cell differentiation and angiogenesis are linked events 
during decidualization (88). Angiogenic factors are secreted by the differentiated decidual cells, 
which are involved in promoting neovascularization at the mesometrial decidua. Uterine deletion 
of Runx1 caused attenuation of connexin 43 expression, which in turn led to reduced expression 
of angiogenic factors such as angiopoietin2 and Vegf-A causing defective angiogenesis in 
decidua of Runx1
d/d
 mice.  
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In summary, our study demonstrates that Runx1 expressed in the stromal cells acts on several 
uterine cell types to regulate critical physiological processes, including stromal differentiation, 
decidual regression, trophoblast invasion, maternal vascular remodeling and immune 
modification (Fig. 23). We propose that this Runx1
d/d 
mouse model will be an important model to 
study human pregnancy disorders such as spontaneous abortion, intra-uterine growth restriction 
and preeclampsia. 
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FIGURES AND TABLES 
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Fig. 1 Induction of Runx1in uterine stromal cells during delayed 
implantation. 
 
The delayed implantation mouse model was used to analyze Runx1 protein 
expression. Uteri were subjected to a delayed embryo implantation protocol and 
collected at (b) 24 h following estrogen treatment and subjected to IHC using anti-
Runx1 antibody. Figures a-b were taken at 4x magnification. Panel c and d 
represents 20x magnification of a & b. The 0-h sample (panel a) represents a 
pregnant uterus obtained from a mouse treated with progesterone alone for three 
days. 
E: embryo 
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Fig. 2 Estrogen induces Runx1 in the uterus 
 
Ovariectomized mice were treated with oil and estrogen and uterine samples were 
collected after 24h. Uterine sections were subjected to immunohistochemistry 
using anti-Runx1 antibody. Panels a & c are oil treated control samples and panels 
b& d are estrogen treated samples. Panels c & d are 20x magnification. 
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Fig. 3 mRNA profile of Runx1 expression during pregnancy 
 
Real time PCR was carried out to study the expression profile of Runx1 
during pregnancy. The relative levels of gene expression at different days of 
pregnancy were determined by setting expression level on day 4 of 
pregnancy as 1.0 and Rplpo, encoding ribosomal protein level was used for 
normalization.n= five, p=< 0.05 
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Fig. 4 Spatio-Temporal expression of Runx1 in mouse uteri during 
pregnancy 
 
Uterine sections of day 4 - day 10 pregnant uteri (panels a-f) were 
subjected to immunohistochemistry analysis using anti-Runx1 antibody.  
E indicates embryo. Hematoxylin is used as counterstain. 
E 
E 
E E 
a b c 
d e f 
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Fig. 5 Detection of RUNX1 in day 8 uteri of Runx1
fl/fl 
and Runx1
d/d
 
mice. 
 
Real time PCR of Runx1 mRNA (A) was examined. mRNA level in 
Runx1
d/d 
 uteri were compared with that of Runx1
fl/fl 
using Rplpo, 
encoding ribosomal protein level for normalization, *p < 0.01. 
Immunohistochemistry of Runx1protein (B) was carried out using anti-
RUNX1 antibody in Runx1
fl/fl
(a) and Runx1
d/d 
(b) uterine sections. 
Western blot analysis (C) of RUNX1 protein was analyzed in uterine 
decidual cell protein extract. Calnexin was used as loading control. 
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Table. 1 Ablation of Runx1 impairs female fertility 
*Results of a six-month breeding experiment. 
‡ 
p=0.0001 
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Table. 2 Deletion of Runx1 does not affect ovarian function 
*p =0.52 
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Fig. 6 Deletion of Runx1 does not affect ovarian function 
 
(A) H&E staining of day 8 pregnant uteri of (a) Runx1
fl/fl 
and (b) Runx1
d/d 
mice 
(B) Serum hormonal levels of estrogen (p=0.078) and progesterone 
(p=0.27) in day 8 pregnant mice (n=8). 
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Fig. 7 Embryo attachment and initial phases of decidualization are 
unaffected in Runx1
d/d
 mice 
 
(A) Day6 pregnant uteri of Runx1
fl/fl 
(a) and Runx1
d/d 
(b) were collected.  
(B) Alkaline phosphatase enzymatic activity was analyzed in frozen 
sections of  Runx1
fl/fl 
(a) and Runx1
d/d 
(b) day7 pregnant uteri.  
(C) mRNA levels of Bmp2 and Cebpb were analyzed by real time 
QPCR.  Level of Rplp0 used as internal control for normalization. 
 *p=0.062 and **p = 0.09,  
E: Embryo 
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Fig. 8 Ablation of Runx1 leads to embryo resorption during  
mid-pregnancy 
 
Day10 and day12 pregnant uteri (A & B) were collected and analyzed. 
Implantation sites of day10 Runx1
fl/fl 
(a,c & e) and Runx1
d/d
 (b,d & f) were 
dissected. Hemorrhaging sites are indicated by arrows. Similarly day12 
implantation sites of Runx1
fl/fl 
(B-g &i) and Runx1
d/d  
 (B-h &j) were 
dissected. Normal and healthy embryos were observed in day10 and 
day12 implantation sites of Runx1
fl/fl 
uteri (a & g), whereas resorbed 
embryos were seen in Runx1
d/d
 uteri (b & h). Dec: decidua and E: 
embryo. 
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  Fig.  9 Histology of H & E stained mid-pregnant implantation sites 
 
Mid-pregnant day 10 A (a- Runx1 
fl/fl 
 & b- Runx1
d/d
)  and 
day 12 B (c- Runx1 
fl/fl
 &d – Runx1 
d/d
) sections were stained with 
hematoxylin and eosin. Double arrow indicates decidua. 
E indicates embryo. 
C. Quantitation of day 10 decidual thickness using ImageJ software. N=8 
*p < 0.0001 
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Fig. 10 Persistent proliferation of mesometrial decidual cells of 
Runx1
d/d
 mice 
 
Day10 uterine sections were colocalized using Ki67 (FITC) and PR 
(Cy3) antibodies. Runx1
fl/fl 
(a&c) Runx1
d/d
 (b & d), a & b are 10x, c & d 
are 20x magnification of day10 sections. Colocalized cells were 
indicated by yellow arrowheads. 
a b 
c d 
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Fig. 11 Modified cell cycle molecules in Runx1
d/d 
decidua 
 
(A) Localization of CCND3 protein in d10 uterine sections of Runx1
fl/fl 
(a & b) and Runx1
d/d 
(c &d) were carried out. 40x magnification of 
boxed regions were shown in b & d. 
(B) QPCR was utilized to measure mRNA levels of Cdkn1b and 
Cdkn1c. The level of Rplp0 was used as internal control for 
normalization. *p < 0.01, **p <0.001 
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Fig. 12 Down regulation of Foxo1 expression due to Runx1 
deletion 
 
Localization of Foxo1 protein in day10 uterine sections of Runx1
fl/fl
 
(a & b) and Runx1
d/d 
mice (c &d). 
20x magnification of boxed area of control and Runx1 
d/d 
sections 
are shown in b & d respectively 
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Fig. 13 Lack of apoptotic cells in day10 Runx1
d/d 
decidua. 
 
TUNEL staining was utilized to investigate apoptosis at day10 pregnancy 
of Runx1
fl/fl
 (a & b) and Runx1
d/d
 (b & d) uterine sections. Apoptotic cells 
are marked by arrows. a & b were 10x, c & d were 20x magnification. 
a b 
c d 
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Fig.  14 Terminal differentiation is attenuated in Runx1
d/d
 decidua 
 
Localization of Prl8a2 (dPRP) protein in day 9 uterine sections of 
Runx1
fl/fl
 (a) and Runx1
d/d 
(b). 
 E : embryo and am: anti mesometrial. 
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Fig. 15 Down regulation of Gja1 in Runx1
d/d 
uteri 
 
Quantitative PCR of Gja1 mRNA in day9 pregnant uteri (A). *p< 0.0001  
Localization of Gja1 protein in day 9 pregnant uterine sections of Runx1
fl/fl 
(B-a)  
and Runx1
d/d 
(B-b) mice.  
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Figure 16.  Reduced expression of angiogenic factors in Runx1
d/d 
uteri 
 
Quantitative PCR of angiopoietin 2 (A) and Vegf-A (B) in day 9 pregnant 
uteri (n=5), * p < 0.001 
Immunolocalization of angiopoietin2 in day 9 uterine sections of Runx1
fl/fl
 
(a) and Runx1
d/d
 (c), and Vegf-A in Runx1
fl/fl 
(b) and Runx1
d/d 
(d).  
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Fig. 17 Impaired angiogenesis in Runx1
d/d
 pregnant uteri 
 
Localization of PECAM on day10 pregnant uteri of Runx1
fl/fl 
(a) and 
Runx1
d/d  
(b)  ms: mesometrium.
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Fig. 18 Spiral artery modification is impaired in Runx1 null decidua 
 
Localization of α-SMA on day 12 Runx1
fl/fl 
(Aa--d) and Runx1
d/d 
 (Be-h) uterine 
sections, a&e are radial arteries of Runx1
fl/fl 
and Runx1
d/d
 ,b &f are spiral 
arteries in myometrium, c& g are in distal endometrium and d& h are in 
proximal endometrium. P: placenta. Dotted lines separate maternal decidua 
from placental labyrinth. 
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Fig. 19 Impaired trophoblast migration in Runx1
d/d 
decidua 
 
Localization of cytokeratin 8 (Troma 1) in day12 Runx1 
fl/fl 
(a) and Runx1 
d/d 
(b) 
uterine sections. 
P: placenta, Dec: decidua and ms: mesometrium. Arrows indicate invading fetal 
trophoblast cells. 
m
s
ms 
P 
P 
D Dec 
ms 
Dec 
P 
a b 
47 
 
 
  
 
 
SA 
SA 
a c 
b d 
 
 P P 
Fig. 20 Maternal-Fetal contact is compromised in Runx1
d/d
 decidua 
 
Colocalization of cytokeratin 8 (cy3) and αSMA (FITC) proteins in d12 
Runx1
fl/fl
 (a& b) and Runx1
d/d
 (c & d) uterine sections. b & d are 20x 
magnification of boxed regions of control and Runx1
d/d 
 sections.  
SA: spiral artery indicated by arrow. P: placenta. Dotted lines separate 
maternal decidua from placenta. 
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Fig. 21 Compromised trophoblast migration in day 15 Runx1
d/d 
decidua 
 
Colocalization of cytokeratin8 (cy3) and αSMA (FITC) in day15 
pregnant Runx1
fl/fl 
 (a & b) and Runx1
d/d
 (c & d) 
20x magnification of boxed area in Runx1 
fl/fl 
(b) and Runx1 
d/d 
(d) 
decidua. Arrow indicates αSMA positive distal spiral arteries in Runx1 
d/d  
decidua (d).   
Dec: decidua, P: placenta. 
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D12 
a 
b 
c 
d 
Fig. 22 Increased uNK cell population in Runx1
d/d 
decidua 
 
Colocalization of DBA (red) and Ki67 (black) in day12 uterine 
sections of Runx1
fl/fl
 (a & b) and Runx1
d/d
 (fig c &d). Colocalized Ki67 
positive proliferating uNK cells are indicated by arrow heads.  
40x magnification of boxed area of a & c were shown in Runx1
fl/fl
 (b) 
and Runx1
d/d
 (d). 
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                   Fig. 23 Summary on the role of Runx1 during pregnancy 
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